Intellectus Partners LLC Reduces Holdings in Docusign Inc. $DOCU

Intellectus Partners LLC trimmed its position in shares of Docusign Inc. (NASDAQ:DOCU) by 17.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,827 shares of the company’s stock after selling 1,000 shares during the quarter. Intellectus Partners LLC’s holdings in Docusign were worth $376,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of DOCU. Private Trust Co. NA boosted its stake in Docusign by 31.5% during the first quarter. Private Trust Co. NA now owns 677 shares of the company’s stock worth $55,000 after buying an additional 162 shares during the period. D.A. Davidson & CO. bought a new stake in shares of Docusign during the first quarter worth $211,000. OneDigital Investment Advisors LLC lifted its position in shares of Docusign by 15.6% during the first quarter. OneDigital Investment Advisors LLC now owns 3,060 shares of the company’s stock worth $249,000 after purchasing an additional 414 shares during the last quarter. IFM Investors Pty Ltd lifted its position in shares of Docusign by 8.9% during the first quarter. IFM Investors Pty Ltd now owns 37,549 shares of the company’s stock worth $3,056,000 after purchasing an additional 3,060 shares during the last quarter. Finally, World Investment Advisors lifted its position in shares of Docusign by 70.4% during the first quarter. World Investment Advisors now owns 4,481 shares of the company’s stock worth $365,000 after purchasing an additional 1,852 shares during the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on DOCU shares. Citigroup lifted their target price on Docusign from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, September 4th. Morgan Stanley lifted their target price on Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, September 8th. Argus reiterated a “hold” rating on shares of Docusign in a research report on Monday, September 8th. Zacks Research upgraded Docusign from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 9th. Finally, Evercore ISI lifted their target price on Docusign from $90.00 to $92.00 and gave the stock an “in-line” rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $94.14.

Insider Transactions at Docusign

In other Docusign news, insider James P. Shaughnessy sold 7,500 shares of the business’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total value of $533,925.00. Following the completion of the transaction, the insider directly owned 55,442 shares in the company, valued at approximately $3,946,915.98. The trade was a 11.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Robert Chatwani sold 13,817 shares of the business’s stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total value of $1,148,192.70. Following the sale, the insider owned 71,162 shares in the company, valued at $5,913,562.20. The trade was a 16.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 102,533 shares of company stock valued at $7,709,933 over the last three months. 1.66% of the stock is currently owned by corporate insiders.

Docusign Price Performance

DOCU stock opened at $73.04 on Tuesday. The business has a 50-day moving average price of $75.14 and a 200 day moving average price of $77.71. The company has a market capitalization of $14.69 billion, a P/E ratio of 54.92, a PEG ratio of 3.64 and a beta of 1.01. Docusign Inc. has a 1-year low of $66.35 and a 1-year high of $107.86.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.